Related Experiment Video
Updated: Dec 20, 2025

16:40
A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
26.7K
Decision Support for Implantable Cardioverter-Defibrillator Replacement: A Pilot Feasibility Randomized Controlled
The Journal of Cardiovascular Nursing
|May 27, 2020
Summary
Decision support for implantable cardioverter-defibrillator (ICD) replacement is feasible and can improve patient knowledge. This intervention aids informed choices regarding ICD device replacement, enhancing decision quality.
Area of Science:
- Cardiology
- Medical Decision Making
- Health Technology Assessment
Background:
- Implantable cardioverter-defibrillators (ICDs) require battery replacement, presenting patients with a significant decision.
- Effective decision support is crucial for patients to align choices with personal preferences.
Purpose of the Study:
- To assess the feasibility of a decision support intervention for patients considering ICD replacement.
- To evaluate the impact of decision support on patient knowledge, decision conflict, and involvement.
Main Methods:
- A pilot randomized feasibility trial involving 30 patients nearing ICD battery depletion.
- Patients were randomized to receive a decision support intervention or usual care.
- Feasibility assessed via recruitment, intervention use, and data completeness; secondary outcomes included knowledge and decision quality.
Main Results:
- The decision support intervention was feasible to deliver, with high data completeness.
- Patients receiving the intervention demonstrated significantly improved knowledge about ICD replacement (77.4% vs 51.1%).
- Acceptance rates for ICD replacement were similar between groups, with one patient in each arm declining.
Conclusions:
- The decision support intervention is feasible for patients facing ICD replacement.
- The intervention shows potential to enhance the quality of decisions regarding ICD replacement.
- Further research is warranted to optimize recruitment and confirm benefits.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
216
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
216
Cardiomyopathy II: Dilated Cardiomyopathy
329
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
329

